Insider Selling: Docusign (NASDAQ:DOCU) CRO Sells $281,040.00 in Stock

Docusign Inc. (NASDAQ:DOCU) CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $46.84, for a total transaction of $281,040.00. Following the transaction, the executive directly owned 79,233 shares of the company’s stock, valued at $3,711,273.72. This represents a 7.04% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Paula Hansen also recently made the following trade(s):

• On Friday, January 2nd, Paula Hansen sold 6,000 shares of Docusign stock. The shares were sold at an average price of $67.05, for a total transaction of $402,300.00.

Docusign Price Performance

Shares of DOCU opened at $48.37 on Friday. The stock has a market cap of $9.40 billion, a P/E ratio of 32.68, a P/E/G ratio of 1.88 and a beta of 0.99. The business’s 50 day moving average price is $47.40 and its 200-day moving average price is $61.71. Docusign Inc. has a 52 week low of $40.16 and a 52 week high of $94.67.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.06. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The company had revenue of $836.86 million during the quarter, compared to analyst estimates of $828.23 million. During the same quarter last year, the company earned $0.86 EPS. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. On average, equities analysts anticipate that Docusign Inc. will post 1.17 EPS for the current year.

Docusign declared that its Board of Directors has authorized a stock repurchase plan on Tuesday, March 17th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to repurchase up to 21% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its shares are undervalued.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Q3 results topped expectations — DOCU reported $1.01 EPS vs. $0.95 consensus and revenue of $836.9M, with revenue up ~7.8% YoY, signaling continued growth and margin improvement. MarketBeat DOCU summary
• Positive Sentiment: Board authorized a $2.0 billion buyback (up to ~21% of shares) — a large repurchase program that management says indicates shares are undervalued and can support the share price over time. MarketBeat DOCU summary
• Positive Sentiment: Institutional accumulation — several large funds (Norges Bank, Capital World, Arrowstreet, Marshall Wace, Woodline) materially increased positions in recent quarters, which can provide steadier demand for the shares. MarketBeat DOCU institutional holdings
• Neutral Sentiment: Analyst mix remains split — consensus is a “Hold” with a $64.67 average target; broker price targets and ratings vary widely (from Underperform to Buy), leaving near‑term analyst-driven directional risk moderate. MarketBeat analyst coverage
• Negative Sentiment: Significant insider selling this week — CEO Allan Thygesen sold 26,250 shares (avg ~$47.78) under a Rule 10b5‑1 plan. This is a sizable reduction in his stake and has likely weighed on sentiment. CEO Form 4
• Negative Sentiment: CRO Paula Hansen and insider James P. Shaughnessy sold 6,000 and 12,000 shares respectively (each at ~\$46.8), both reported as executed under pre-arranged 10b5‑1 plans — multiple senior exits in one day can pressure sentiment despite plan disclosures. CRO Form 4
• Negative Sentiment: Non‑executive director Mary Agnes Wilderotter sold 3,000 shares (~\$48.15), further adding to the week’s insider selling flow. Director Form 4

Hedge Funds Weigh In On Docusign

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Central Pacific Bank Trust Division purchased a new stake in shares of Docusign during the 4th quarter valued at about $25,000. Modus Advisors LLC purchased a new position in shares of Docusign during the fourth quarter valued at approximately $27,000. Torren Management LLC bought a new position in Docusign during the fourth quarter valued at approximately $28,000. Aventura Private Wealth LLC purchased a new stake in Docusign in the fourth quarter worth approximately $30,000. Finally, True Wealth Design LLC grew its position in Docusign by 105.2% in the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after purchasing an additional 222 shares during the period. Institutional investors own 77.64% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on DOCU. HSBC set a $53.00 price objective on shares of Docusign in a research report on Friday, February 13th. Piper Sandler dropped their target price on shares of Docusign from $75.00 to $52.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 18th. Wells Fargo & Company cut their price target on shares of Docusign from $75.00 to $60.00 and set an “equal weight” rating on the stock in a report on Wednesday, March 18th. BTIG Research reissued a “buy” rating and set a $70.00 price target on shares of Docusign in a research report on Wednesday, March 18th. Finally, Needham & Company LLC restated a “hold” rating on shares of Docusign in a report on Tuesday, March 10th. Five investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $64.67.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.